Details of the Drug
General Information of Drug (ID: DM31M4V)
| Drug Name |
Autologous endothelial progenitor cell therapy
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Autologous endothelial progenitor cell therapy (ischemia); Autologous endothelial progenitor cell therapy (ischemia), IBRI; Autologous stem cell therapy (critical limb ischemia), IBRI; Autologous CD34+ cells (peripheral vascular disease), IBRI
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
